Achenbach R - Search Results

1

[Valve calcification in Werner's syndrome].

Monroy S, Pereiro G, Graziano A, Cola H, Palombo M, Achenbach R. Monroy S, et al. Among authors: achenbach r. Medicina (B Aires). 2010;70(4):372. Medicina (B Aires). 2010. PMID: 20679061 Spanish. No abstract available.

2

Paracoccidioidomycosis: unusual clinical presentation and utility of computerized tomography scanning for diagnosis.

Achenbach R, Negroni R, Khaski S, Lococo L, Beresñak A, Gai L. Achenbach R, et al. Int J Dermatol. 2002 Dec;41(12):881-2. doi: 10.1046/j.1365-4362.2002.01424.x. Int J Dermatol. 2002. PMID: 12492976 No abstract available.

3

Letter to the editor.

Achenbach RE. Achenbach RE. Dermatol Pract Concept. 2011 Jan 31;1(1):83-4. doi: 10.5826/dpc.dp0101a17. eCollection 2011. Dermatol Pract Concept. 2011. PMID: 24396726 Free PMC article. No abstract available.

4

Topical fish oil in psoriasis--a controlled and blind study.

Escobar SO, Achenbach R, Iannantuono R, Torem V. Escobar SO, et al. Among authors: achenbach r. Clin Exp Dermatol. 1992 May;17(3):159-62. doi: 10.1111/j.1365-2230.1992.tb00194.x. Clin Exp Dermatol. 1992. PMID: 1451289 Clinical Trial.

5

A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies.

Agrelo R, Sutz MA, Setien F, Aldunate F, Esteller M, Da Costa V, Achenbach R. Agrelo R, et al. Among authors: achenbach r. Epigenetics. 2015;10(4):329-41. doi: 10.1080/15592294.2015.1027853. Epigenetics. 2015. PMID: 25830902 Free PMC article.

6

Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.

Bechara FG, Sand M, Achenbach RK, Sand D, Altmeyer P, Hoffmann K. Bechara FG, et al. Among authors: achenbach rk. Dermatol Surg. 2007 Aug;33(8):924-7. doi: 10.1111/j.1524-4725.2007.33193.x. Dermatol Surg. 2007. PMID: 17661934

7

Focal hyperhidrosis of the anal fold: a simple technique for diagnosis and evaluation of therapy.

Bechara FG, Sand M, Sand D, Achenbach RK, Altmeyer P, Hoffmann K. Bechara FG, et al. Among authors: achenbach rk. Br J Dermatol. 2006 Oct;155(4):858. doi: 10.1111/j.1365-2133.2006.07406.x. Br J Dermatol. 2006. PMID: 16965453 No abstract available.

8

Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.

Kereiakes DJ, Lincoff AM, Anderson KM, Achenbach R, Patel K, Barnathan E, Califf RM, Topol EJ; EPIC Investigators; EPILOG investigators; EPISTENT investigators. Kereiakes DJ, et al. Among authors: achenbach r. Am J Cardiol. 2002 Sep 15;90(6):628-30. doi: 10.1016/s0002-9149(02)02568-7. Am J Cardiol. 2002. PMID: 12231090 Clinical Trial. No abstract available.

9

[When sweating impairs life style. How your patients can become "dry". Interview by Petra Eiden].

Achenbach RK. Achenbach RK. MMW Fortschr Med. 2000 Jul 20;142(28-29):14. MMW Fortschr Med. 2000. PMID: 10959154 German. No abstract available.

10

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.

Kereiakes DJ, Berkowitz SD, Lincoff AM, Tcheng JE, Wolski K, Achenbach R, Melsheimer R, Anderson K, Califf RM, Topol EJ. Kereiakes DJ, et al. Among authors: achenbach r. Am Heart J. 2000 Jul;140(1):74-80. doi: 10.1067/mhj.2000.106615. Am Heart J. 2000. PMID: 10874266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters